Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner

CONCLUSION: Dauricine may be a promising FLT4 inhibitor for the treatment of NSCLC.PMID:38321898 | DOI:10.2174/0115680096282997240101192452

Source: Current Cancer Drug Targets - February 7, 2024 Category: Cancer & Oncology Authors: Jinna Liang Panpan Lei Xinyue Su Jiapan Gao Bingxi Ren Yuxiu Zhang Xiaoyu Ma Weina Ma Source Type: research